학술논문
237TiP GUIDE.MRD: A Consortium guiding multi-modal therapies against minimal residual disease (MRD) by liquid biopsy to assess implementation of circulating tumor DNA (ctDNA) in clinical practice to improve patient outcomes
Document Type
Abstract
Author
Source
In Annals of Oncology October 2023 34 Supplement 2:S276-S277
Subject
Language
ISSN
0923-7534